在心脏骤停中心接受治疗能否改善院外心脏骤停后的结局——一项系统评价
本系统评价遵循PRISMA指南,检索Embase、MEDLINE和Cochrane Library(CENTRAL)自建库至2018年8月1日的文献,纳入17项观察性研究,对院外心脏骤停(OHCA)患者进行Meta分析,主要终点为30天良好神经功能存活和出院良好神经功能存活。仅合并调整后分析显示,CAC治疗与出院良好神经功能存活改善相关(OR 2.22,95%CI 1.74-2.84)及出院存活改善相关(OR 1.85,95%CI 1.46-2.34),但与30天良好神经功能存活(OR 2.92,95%CI 0.68-12.48)和30天存活(OR 2.14,95%CI 0.73-6.29)无显著关联。总体证据确定性极低。作者认为仍需高质量数据来充分阐明CAC的影响。
要点
- 仅合并调整后分析:CAC治疗与出院良好神经功能存活改善相关(OR 2.22,95%CI 1.74-2.84)。
- 仅合并调整后分析:CAC治疗与出院存活改善相关(OR 1.85,95%CI 1.46-2.34)。
- CAC治疗与30天良好神经功能存活(OR 2.92,95%CI 0.68-12.48)及30天存活(OR 2.14,95%CI 0.73-6.29)无显著关联。
- 总体证据确定性极低;作者认为仍需高质量数据来充分阐明CAC的影响。
适用人群与场景
- 成人非创伤性心脏骤停尝试复苏后患者(院外心脏骤停,OHCA)。
研究设计与关键结果
- 系统评价遵循PRISMA指南,检索Embase、MEDLINE和Cochrane Library(CENTRAL)自建库至2018年8月1日,纳入随机对照试验和非随机研究,由两名评价者独立筛选文献、提取数据并评估质量,使用ROBINS-I工具评估偏倚风险、GRADEpro评估证据质量,PROSPERO注册号CRD 42018093369。
- 纳入17项观察性研究,对院外心脏骤停(OHCA)患者数据进行Meta分析;总体证据确定性极低。
- 仅合并调整后分析:与在其他医院治疗相比,CAC治疗与30天良好神经功能存活(OR 2.92,95%CI 0.68-12.48)及30天存活(OR 2.14,95%CI 0.73-6.29)无显著关联。
- 仅合并调整后分析:CAC治疗患者出院良好神经功能存活改善(OR 2.22,95%CI 1.74-2.84),出院存活改善(OR 1.85,95%CI 1.46-2.34)。
证据类型、等级与局限
- 证据类型:系统评价与Meta分析,纳入17项观察性研究。
- 证据确定性:极低(GRADEpro评估)。
- 局限:证据确定性极低;作者认为仍需高质量数据来充分阐明CAC的影响。
对床旁实践的改变
- 作者认为,极低确定性证据提示在CAC进行心脏骤停后治疗与出院时结局改善相关。
- 作者认为,仍需高质量数据来充分阐明CAC的影响。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
AIM: To perform a systematic review to answer 'In adults with attempted resuscitation after non-traumatic cardiac arrest does care at a specialised cardiac arrest centre (CAC) compared to care in a healthcare facility not designated as a specialised cardiac arrest centre improve patient outcomes?'
METHODS: The PRISMA guidelines were followed. We searched bibliographic databases (Embase, MEDLINE and the Cochrane Library (CENTRAL)) from inception to 1st August 2018. Randomised controlled trials (RCTs) and non-randomised studies were eligible for inclusion. Two reviewers independently scrutinized studies for relevance, extracted data and assessed quality of studies. Risk of bias of studies and quality of evidence were assessed using ROBINS-I tool and GRADEpro respectively. Primary outcomes were survival to 30 days with favourable neurological outcomes and survival to hospital discharge with favourable neurological outcomes. Secondary outcomes were survival to 30 days, survival to hospital discharge and return of spontaneous circulation (ROSC) post-hospital arrival for patients with ongoing resuscitation. This systematic review was registered in PROSPERO (CRD 42018093369) RESULTS: We included data from 17 observational studies on out-of-hospital cardiac arrest (OHCA) patients in meta-analyses. Overall, the certainty of evidence was very low. Pooling data from only adjusted analyses, care at CAC was not associated with increased likelihood of survival to 30 days with favourable neurological outcome (OR 2.92, 95% CI 0.68-12.48) and survival to 30 days (OR 2.14, 95% CI 0.73-6.29) compared to care at other hospitals. Whereas patients cared for at CACs had improved survival to hospital discharge with favourable neurological outcomes (OR 2.22, 95% CI 1.74-2.84) and survival to hospital discharge (OR 1.85, 95% CI 1.46-2.34).
CONCLUSIONS: Very low certainty of evidence suggests that post-cardiac arrest care at CACs is associated with improved outcomes at hospital discharge. There remains a need for high quality data to fully elucidate the impact of CACs.
参考来源
- Yeung J, Matsuyama T, Bray J, et al. Does care at a cardiac arrest centre improve outcome after out-of-hospital cardiac arrest? - A systematic review. Resuscitation. 2019. PMID: 30779976. doi:10.1016/j.resuscitation.2019.02.006
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。